Titan Pharmaceuticals, Inc. (NASDAQOTCBB:TTNP)

CAPS Rating: 1 out of 5

A biopharmaceutical company developing proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, bone disease and other disorders.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 10/24/2013 3:55:57 PM : Underperform Start Price: $0.89 TTNP Score: +5.86

pessimistic going forward

Featured Broker Partners


Advertisement